United American Healthcare Corporation (UAHC)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -59 Thousand USD | 30.59% |
| 2022 | -85 Thousand USD | 61.36% |
| 2021 | 660 Thousand USD | -11.68% |
| 2020 | -91 Thousand USD | 73.77% |
| 2019 | -33.28 Million USD | 0.0% |
| 2013 | -284 Thousand USD | -10.73% |
| 2012 | 1.41 Million USD | 774.36% |
| 2011 | -647 Thousand USD | 93.41% |
| 2010 | -351 Thousand USD | 42.18% |
| 2009 | -5.22 Million USD | -276.77% |
| 2008 | -4.59 Million USD | 145.9% |
| 2007 | 1.76 Million USD | 29.11% |
| 2006 | -932 Thousand USD | -73.99% |
| 2005 | 1.64 Million USD | -10.68% |
| 2004 | 6.31 Million USD | -19.3% |
| 2003 | 7.06 Million USD | 364.89% |
| 2002 | -3.3 Million USD | -114.53% |
| 2001 | -3.3 Million USD | 1568.26% |
| 2000 | 1.36 Million USD | -78.35% |
| 1999 | 1.36 Million USD | 386.36% |
| 1998 | 6.3 Million USD | -344.44% |
| 1997 | -2.2 Million USD | -96.31% |
| 1996 | 900 Thousand USD | 41.86% |
| 1995 | 17.2 Million USD | 59.26% |
| 1994 | 10.8 Million USD | 44.0% |
| 1993 | 7.5 Million USD | 47.06% |
| 1992 | 5.1 Million USD | -15.0% |
| 1991 | 5.1 Million USD | 64.52% |
| 1990 | 3.1 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -12 Thousand USD | 0.0% |
| 2023 Q2 | -28 Thousand USD | 9.68% |
| 2023 Q1 | -31 Thousand USD | 0.0% |
| 2023 Q3 | - USD | 100.0% |
| 2023 FY | - USD | 30.59% |
| 2022 FY | - USD | 61.36% |
| 2022 Q2 | -40 Thousand USD | -73.91% |
| 2022 Q1 | -23 Thousand USD | 0.0% |
| 2021 Q1 | -84 Thousand USD | 0.0% |
| 2021 FY | - USD | -11.68% |
| 2021 Q2 | -82 Thousand USD | 2.38% |
| 2020 FY | - USD | 73.77% |
| 2019 FY | - USD | 0.0% |
| 2018 Q2 | 500 Thousand USD | 933.33% |
| 2018 Q1 | -60 Thousand USD | 0.0% |
| 2018 Q3 | 1.17 Million USD | 134.0% |
| 2018 Q4 | 208 Thousand USD | -82.22% |
| 2017 Q3 | 361.67 USD | 0.0% |
| 2016 Q3 | 275.33 USD | 0.0% |
| 2014 Q2 | 314 Thousand USD | 926.32% |
| 2014 Q1 | -38 Thousand USD | 0.0% |
| 2014 Q3 | 149 Thousand USD | -52.55% |
| 2013 Q3 | 55 Thousand USD | -90.57% |
| 2013 Q2 | 583 Thousand USD | -13.76% |
| 2013 Q1 | 676 Thousand USD | 129.15% |
| 2013 FY | - USD | -10.73% |
| 2012 Q2 | 2.14 Million USD | 12741.18% |
| 2012 Q4 | 295 Thousand USD | -13.24% |
| 2012 FY | - USD | 774.36% |
| 2012 Q1 | -17 Thousand USD | -107.17% |
| 2012 Q3 | 340 Thousand USD | -84.18% |
| 2011 Q1 | 303 Thousand USD | 222.67% |
| 2011 FY | - USD | 93.41% |
| 2011 Q4 | 237 Thousand USD | 30.22% |
| 2011 Q3 | 182 Thousand USD | -34.53% |
| 2011 Q2 | 278 Thousand USD | -8.25% |
| 2010 FY | - USD | 42.18% |
| 2010 Q3 | -778 Thousand USD | 37.86% |
| 2010 Q2 | -1.25 Million USD | 9.93% |
| 2010 Q1 | -1.39 Million USD | -23.78% |
| 2010 Q4 | -247 Thousand USD | 68.25% |
| 2009 Q2 | -4.62 Million USD | -47.48% |
| 2009 Q4 | -1.12 Million USD | 28.15% |
| 2009 Q3 | -1.56 Million USD | 66.18% |
| 2009 Q1 | -3.13 Million USD | -201.93% |
| 2009 FY | - USD | -276.77% |
| 2008 Q3 | 331 Thousand USD | 1073.53% |
| 2008 Q2 | -34 Thousand USD | -100.72% |
| 2008 Q1 | 4.7 Million USD | 1053.43% |
| 2008 FY | - USD | 145.9% |
| 2008 Q4 | -1.03 Million USD | -413.6% |
| 2007 Q3 | 133 Thousand USD | 246.15% |
| 2007 Q2 | -91 Thousand USD | -2933.33% |
| 2007 Q4 | 408 Thousand USD | 206.77% |
| 2007 FY | - USD | 29.11% |
| 2007 Q1 | -3000.00 USD | -101.1% |
| 2006 Q3 | 415 Thousand USD | 280.73% |
| 2006 FY | - USD | -73.99% |
| 2006 Q1 | 520 Thousand USD | -0.57% |
| 2006 Q2 | 109 Thousand USD | -79.04% |
| 2006 Q4 | 273 Thousand USD | -34.22% |
| 2005 FY | - USD | -10.68% |
| 2005 Q1 | 1.86 Million USD | -5.42% |
| 2005 Q2 | 819 Thousand USD | -56.16% |
| 2005 Q4 | 523 Thousand USD | 6.73% |
| 2005 Q3 | 490 Thousand USD | -40.17% |
| 2004 FY | - USD | -19.3% |
| 2004 Q4 | 1.97 Million USD | 20.13% |
| 2004 Q3 | 1.64 Million USD | -29.29% |
| 2004 Q2 | 2.32 Million USD | 25.61% |
| 2004 Q1 | 1.85 Million USD | 57.26% |
| 2003 Q4 | 1.17 Million USD | -18.49% |
| 2003 Q2 | 759 Thousand USD | -14.53% |
| 2003 Q1 | 895 Thousand USD | -75.36% |
| 2003 FY | - USD | 364.89% |
| 2003 Q3 | 1.44 Million USD | 90.25% |
| 2002 Q1 | 516 Thousand USD | -74.61% |
| 2002 Q2 | -10.83 Million USD | -2199.22% |
| 2002 Q3 | 3.22 Million USD | 129.75% |
| 2002 Q4 | 3.15 Million USD | 11.82% |
| 2002 FY | - USD | -114.53% |
| 2001 Q1 | -5.88 Million USD | -407.15% |
| 2001 Q3 | 3.17 Million USD | -74.61% |
| 2001 Q4 | 2.03 Million USD | -36.08% |
| 2001 FY | - USD | 1568.26% |
| 2001 Q2 | 12.52 Million USD | 312.65% |
| 2000 Q1 | 5.52 Million USD | 3605.0% |
| 2000 Q4 | 1.91 Million USD | -14.91% |
| 2000 FY | - USD | -78.35% |
| 2000 Q2 | -5.36 Million USD | -176.55% |
| 2000 Q3 | 2.25 Million USD | 141.99% |
| 1999 Q3 | 860 Thousand USD | -86.49% |
| 1999 FY | - USD | 386.36% |
| 1999 Q4 | 200 Thousand USD | -140.0% |
| 1999 Q1 | 800 Thousand USD | -66.67% |
| 1999 Q2 | 3.7 Million USD | 3600.0% |
| 1998 Q2 | 3.3 Million USD | 269.57% |
| 1998 Q3 | 1.6 Million USD | -94.87% |
| 1998 Q4 | 800 Thousand USD | -50.0% |
| 1998 FY | - USD | -344.44% |
| 1998 Q1 | -6.3 Million USD | -25.45% |
| 1997 Q2 | -7.9 Million USD | -332.35% |
| 1997 FY | - USD | -96.31% |
| 1997 Q3 | -1.1 Million USD | 79.75% |
| 1997 Q1 | 3.4 Million USD | 61.9% |
| 1997 Q4 | -5 Million USD | -243.75% |
| 1996 FY | - USD | 41.86% |
| 1996 Q4 | -500 Thousand USD | -4.55% |
| 1996 Q3 | 2.2 Million USD | -78.43% |
| 1996 Q2 | 6.9 Million USD | 537.5% |
| 1996 Q1 | 1.4 Million USD | -44.83% |
| 1995 Q2 | 300 Thousand USD | -101.67% |
| 1995 FY | - USD | 59.26% |
| 1995 Q4 | 2.9 Million USD | -19.44% |
| 1995 Q3 | 3.7 Million USD | 3700.0% |
| 1995 Q1 | 5.4 Million USD | 7.14% |
| 1994 Q2 | 4.1 Million USD | 60.87% |
| 1994 Q1 | 2.6 Million USD | 4.55% |
| 1994 FY | - USD | 44.0% |
| 1994 Q4 | 5.2 Million USD | 0.0% |
| 1994 Q3 | 5.2 Million USD | 51.35% |
| 1993 Q1 | 1 Million USD | -33.33% |
| 1993 FY | - USD | 47.06% |
| 1993 Q4 | 2.5 Million USD | -26.67% |
| 1993 Q3 | 3 Million USD | 3.45% |
| 1993 Q2 | 2.9 Million USD | 190.0% |
| 1992 Q1 | 2 Million USD | 38.46% |
| 1992 Q2 | 1 Million USD | -66.67% |
| 1992 Q3 | 1.9 Million USD | 183.33% |
| 1992 FY | - USD | -15.0% |
| 1992 Q4 | 1.6 Million USD | -11.76% |
| 1991 Q3 | 1.7 Million USD | -16.67% |
| 1991 Q1 | 1.6 Million USD | -83.15% |
| 1991 Q2 | 1.9 Million USD | 20.0% |
| 1991 FY | - USD | 93.55% |
| 1991 Q4 | 1.5 Million USD | -13.33% |
| 1990 FY | - USD | 0.0% |
| 1990 Q2 | -15.4 Million USD | -348.39% |
| 1990 Q4 | 8.9 Million USD | 1.14% |
| 1990 Q1 | 6.2 Million USD | 0.0% |
| 1990 Q3 | 8.8 Million USD | 157.14% |
| 1989 Q3 | 6.2 Million USD | 0.0% |
| 1989 Q4 | 6.2 Million USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| CVR Medical Corp. | - USD | Infinity% |
| BioElectronics Corporation | -274.29 Thousand USD | 78.49% |
| IR-Med Inc. | -4.89 Million USD | 98.794% |
| Polarean Imaging plc | -11.19 Million USD | 99.473% |
| Medical Supply International USA, Inc. | 456.06 Thousand USD | 112.937% |
| Avitar, Inc. | -1.66 Million USD | 96.462% |
| AVITA Medical, Inc. | -39.56 Million USD | 99.851% |
| Manhattan Scientifics, Inc. | -1.16 Million USD | 94.931% |
| Össur hf. | 137.38 Million USD | 100.043% |
| Zecotek Photonics Inc. | -3.44 Million USD | 98.286% |
| QHSLab, Inc. | -91.29 Thousand USD | 35.373% |
| Wellstar International, Inc. | -1.35 Million USD | 95.651% |
| Össur hf. | 137.38 Million USD | 100.043% |
| Bionovate Technologies Corp | - USD | Infinity% |
| EKF Diagnostics Holdings plc | 9.77 Million USD | 100.604% |
| Escalon Medical Corp. | -58.46 Thousand USD | -0.922% |
| Aurora Spine Corporation | -454.37 Thousand USD | 87.015% |
| BrainsWay Ltd. | -2.31 Million USD | 97.447% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| NewCardio, Inc. | -9.37 Million USD | 99.371% |
| Hamilton Thorne Ltd. | 5.52 Million USD | 101.069% |
| Vivos Inc. | -2.79 Million USD | 97.888% |
| MicroPort Scientific Corporation | -347.57 Million USD | 99.983% |
| Kelyniam Global, Inc. | -197.69 Thousand USD | 70.155% |
| REMSleep Holdings, Inc. | -1.66 Million USD | 96.464% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | 84.429% |
| Nanomix Corporation | -8.13 Million USD | 99.275% |
| Theraclion SA | -2.05 Million USD | 97.123% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Wellness Center USA, Inc. | -707.03 Thousand USD | 91.655% |
| Positron Corporation | -1.45 Million USD | 95.937% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | -1.72 Million USD | 96.574% |
| Lombard Medical, Inc. | -28.06 Million USD | 99.79% |
| ALR Technologies Inc. | -6.4 Million USD | 99.078% |
| Stratec SE | 39.91 Million USD | 100.148% |
| Vycor Medical, Inc. | 100.94 Thousand USD | 158.449% |
| Heart Tronics, Inc. | -14.85 Million USD | 99.603% |
| Nu-Med Plus, Inc. | -118.25 Thousand USD | 50.11% |
| Perimeter Medical Imaging AI, Inc. | -13.27 Million USD | 99.556% |
| SANUWAVE Health, Inc. | -9.15 Million USD | 99.355% |
| VMS Rehab Systems, Inc. | -68.55 USD | -85968.563% |
| Guided Therapeutics, Inc. | -3.12 Million USD | 98.113% |
| Ingen Technologies, Inc. | -8639.00 USD | -582.949% |
| Odyssey Group International, Inc. | -2.13 Million USD | 97.241% |
| ECGI Holdings, Inc. | -2.99 Million USD | 98.027% |
| Capital Group Holdings, Inc. | -629.18 Thousand USD | 90.623% |
| ADM Tronics Unlimited, Inc. | -514.02 Thousand USD | 88.522% |
| Urologix, Inc. | -6.34 Million USD | 99.07% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.23 Million USD | 95.239% |
| Nexeon MedSystems Inc. | -765.96 Thousand USD | 92.297% |
| SS Innovations International, Inc. | -20.37 Million USD | 99.71% |
| Qualis Innovations, Inc. | -222.81 Thousand USD | 73.521% |
| Smith & Nephew plc | 1 Billion USD | 100.006% |
| NIOX Group Plc | 11.07 Million USD | 100.533% |
| Fuse Medical, Inc. | 1.83 Million USD | 103.215% |
| Broncus Holding Corporation | -25.19 Million USD | 99.766% |
| Brain Scientific Inc. | -7.93 Million USD | 99.256% |
| Pressure BioSciences, Inc. | -9.39 Million USD | 99.372% |
| Health Logic Interactive Inc. | -18.4 Thousand USD | -220.652% |